Medicus Pharma Launches 12-Part Media Campaign With New to The Street | MDCX

Medicus Pharma (NASDAQ: MDCX) has entered a 12-part, 1-year strategic media agreement with New to The Street to expand its visibility across television, digital platforms, and outdoor advertising. The campaign will showcase the company’s clinical progress and long-term growth strategy to a broad investor audience.

The initiative will highlight Medicus’ pipeline, including Skinject, a localized immuno-oncology platform targeting non-melanoma skin cancers and rare conditions such as Gorlin syndrome. With a multi-billion-dollar market opportunity, the company is positioning itself for increased awareness and investor engagement.

#MedicusPharma
#MDCX
#Biotech
#InvestorRelations
#FinancialMedia
#HealthcareInnovation
#ClinicalTrials
#Oncology
#SkinCancer
#DrugDevelopment
#DigitalMarketing
#BrandAwareness
#Pharmaceuticals
#JaneKing
#NewsOut